Method for administering tandospirone
AssigneeAlza Corporation
InventorsAtul Devdatt Ayer, Dana A. Ridzon
Life of this patent
Estimating the term…
Abstract
A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient. A method is provided for administering the drug of the formula for producing the intended therapy.
Claims5
A method for treating depression in a patient in need of therapy, wherein the method comprises:
- admitting orally into the patient a solid dosage form selected from the group consisting of osmotic, diffusion, bioerosion and ion-exchange comprising 1 mg to 750 mg of a member selected from the group consisting of tandospirone and its pharmaceutically acceptable salts, which member is administered at a dosage controlled-rate of 1 mg to 20 mg per hour over a period of 24 hours by the dosage form to provide antidepressant therapy in the patient.
A method for treating depressant disorders in a patient in need of antidepressant therapy, wherein the method comprises the step of:
- orally admitting into the patient a solid dosage form selected from the group consisting of osmotic, diffusion, bioerosion and ion-exchange comprising 1 mg to 750 mg of tandospirone;
- administering the tandospirone to the patient;
- and wherein the method is characterized in that the rate of release of 1 mg to 20 mg per hour of tandospirone versus time up to 24 hours is dosage form controlled tandospirone administration to the patient.
A method for treating anxiety in a patient in need of anti-anxiety therapy, where the method comprises:
- admitting orally a solid dosage form comprising 1 mg to 750 mg of anti-anxiety tandospirone into the patient that is administered at a dosage form controlled rate of 1 mg to 20 mg per hour by a method selected from the group consisting of osmotic, diffusion, bioerosion and ion-exchange over an extended period to provide anti-anxiety tandospirone therapy to the patient.
The method for treating anxiety in a patient in need of anti-anxiety therapy, wherein the tandospirone is tandospirone citrate.
Dependencies are inferred from the claim text.